Matches in SemOpenAlex for { <https://semopenalex.org/work/W3115343894> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W3115343894 endingPage "413" @default.
- W3115343894 startingPage "407" @default.
- W3115343894 abstract "Cyclophosphamide (CLP), a cytotoxic alkylating agent with immunosuppressive and antitumor properties is used in the treatment of different types of cancers, but it is known to cause toxicity-induced changes to the body tissues. Melatonin, an antioxidant mainly secreted by the pineal gland has protective properties especially against tissue toxicity. This study was aimed at investigating the role of melatonin (MLT) in cyclophosphamide-induced toxicity of the liver and kidney using serum biochemical analysis and histopathology in adult Wistar rats. Twenty-four adult male Wistar rats were grouped into four (n=6): group 1 was injected intraperitoneally with 0.2mL of normal saline for 14 days, group 2 was injected with 10mg/kg of melatonin intraperitoneally for 14 days, group 3 was injected intraperitoneally with 0.2mL of normal saline for 14 days and 150mg/kg of CLP on the 15th day and in group 4, the rats were injected with 10mg/kg of melatonin for 14 days and 150mg/kg of CLP on the 15th day. Forty-eight hours after the last treatment, the rats were weighed; blood samples collected for biochemical analysis while liver and kidney samples were processed for histology. The results revealed that CLP-treated rats had hypokalemia and hypochloremia with a significant increase in the levels of liver and kidney function markers. Histopathological analysis showed congested central vein and widened sinusoids in the liver, while there were widened as well as congested urinary spaces and loop of Henle, with loss of glomerular epithelia in the kidneys. The rats treated with melatonin and CLP showed improvement in body weight, biochemical parameters of hepatic and renal functions as well as improved tissue conditions. In conclusion, a pre-treatment with melatonin is recommended in cyclophosphamide therapy." @default.
- W3115343894 created "2021-01-05" @default.
- W3115343894 creator A5006835616 @default.
- W3115343894 creator A5026765731 @default.
- W3115343894 creator A5028065320 @default.
- W3115343894 creator A5030999598 @default.
- W3115343894 creator A5039925179 @default.
- W3115343894 creator A5043095961 @default.
- W3115343894 creator A5060622652 @default.
- W3115343894 creator A5063857672 @default.
- W3115343894 date "2020-09-30" @default.
- W3115343894 modified "2023-09-23" @default.
- W3115343894 title "Melatonin Protects Against Cyclophosphamide-Induced Hepatic and Renal Alterations in Rats" @default.
- W3115343894 hasPublicationYear "2020" @default.
- W3115343894 type Work @default.
- W3115343894 sameAs 3115343894 @default.
- W3115343894 citedByCount "0" @default.
- W3115343894 crossrefType "journal-article" @default.
- W3115343894 hasAuthorship W3115343894A5006835616 @default.
- W3115343894 hasAuthorship W3115343894A5026765731 @default.
- W3115343894 hasAuthorship W3115343894A5028065320 @default.
- W3115343894 hasAuthorship W3115343894A5030999598 @default.
- W3115343894 hasAuthorship W3115343894A5039925179 @default.
- W3115343894 hasAuthorship W3115343894A5043095961 @default.
- W3115343894 hasAuthorship W3115343894A5060622652 @default.
- W3115343894 hasAuthorship W3115343894A5063857672 @default.
- W3115343894 hasConcept C126322002 @default.
- W3115343894 hasConcept C134018914 @default.
- W3115343894 hasConcept C142724271 @default.
- W3115343894 hasConcept C2776694085 @default.
- W3115343894 hasConcept C2776755627 @default.
- W3115343894 hasConcept C2777397205 @default.
- W3115343894 hasConcept C2778182776 @default.
- W3115343894 hasConcept C2780091579 @default.
- W3115343894 hasConcept C29730261 @default.
- W3115343894 hasConcept C544855455 @default.
- W3115343894 hasConcept C57742111 @default.
- W3115343894 hasConcept C71924100 @default.
- W3115343894 hasConceptScore W3115343894C126322002 @default.
- W3115343894 hasConceptScore W3115343894C134018914 @default.
- W3115343894 hasConceptScore W3115343894C142724271 @default.
- W3115343894 hasConceptScore W3115343894C2776694085 @default.
- W3115343894 hasConceptScore W3115343894C2776755627 @default.
- W3115343894 hasConceptScore W3115343894C2777397205 @default.
- W3115343894 hasConceptScore W3115343894C2778182776 @default.
- W3115343894 hasConceptScore W3115343894C2780091579 @default.
- W3115343894 hasConceptScore W3115343894C29730261 @default.
- W3115343894 hasConceptScore W3115343894C544855455 @default.
- W3115343894 hasConceptScore W3115343894C57742111 @default.
- W3115343894 hasConceptScore W3115343894C71924100 @default.
- W3115343894 hasIssue "3" @default.
- W3115343894 hasLocation W31153438941 @default.
- W3115343894 hasOpenAccess W3115343894 @default.
- W3115343894 hasPrimaryLocation W31153438941 @default.
- W3115343894 hasRelatedWork W1540043217 @default.
- W3115343894 hasRelatedWork W2017385818 @default.
- W3115343894 hasRelatedWork W2135487989 @default.
- W3115343894 hasRelatedWork W2139053153 @default.
- W3115343894 hasRelatedWork W2370295429 @default.
- W3115343894 hasRelatedWork W2389869650 @default.
- W3115343894 hasRelatedWork W2782519559 @default.
- W3115343894 hasRelatedWork W2802717322 @default.
- W3115343894 hasRelatedWork W2912466796 @default.
- W3115343894 hasRelatedWork W2912736183 @default.
- W3115343894 hasRelatedWork W2913967948 @default.
- W3115343894 hasRelatedWork W2966576928 @default.
- W3115343894 hasRelatedWork W2973880280 @default.
- W3115343894 hasRelatedWork W2991092409 @default.
- W3115343894 hasRelatedWork W3008600171 @default.
- W3115343894 hasRelatedWork W3021280322 @default.
- W3115343894 hasRelatedWork W3025082958 @default.
- W3115343894 hasRelatedWork W3033062607 @default.
- W3115343894 hasRelatedWork W47312741 @default.
- W3115343894 hasRelatedWork W2186670952 @default.
- W3115343894 hasVolume "23" @default.
- W3115343894 isParatext "false" @default.
- W3115343894 isRetracted "false" @default.
- W3115343894 magId "3115343894" @default.
- W3115343894 workType "article" @default.